Imaging VEGF receptor expression to identify accelerated atherosclerosis.

Abstract:

BACKGROUND:The biology of the vulnerable plaque includes increased inflammation and rapid growth of vasa vasorum, processes that are associated with enhanced vascular endothelial growth factor (VEGF)/ imaging receptors for VEGF (VEGFR) signaling and are accelerated in diabetes. This study was designed to test the hypothesis that VEGFRs in atherosclerotic plaques with a SPECT tracer scVEGF-PEG-DOTA/(99m)Tc (scV/Tc) can identify accelerated atherosclerosis in diabetes. METHODS:Male apolipoprotein E null (ApoE(-/-)) mice (6 weeks of age) were made diabetic (n = 10) or left as non-diabetic (n = 13). At 26 to 28 weeks of age, 5 non-diabetic mice were injected with functionally inactivated scV/Tc (in-scV/Tc) that does not bind to VEGF receptors, while 8 non-diabetic and 10 diabetic mice were injected with scV/Tc. After blood pool clearance, at 3 to 4 h post-injection, mice were injected with CT contrast agent and underwent SPECT/CT imaging. From the scans, regions of interest (ROI) were drawn on serial transverse sections comprising the proximal aorta and the percentage of injected dose (%ID) in ROIs was calculated. At the completion of imaging, mice were euthanized, proximal aorta explanted for gamma well counting to determine the percentage of injected dose per gram (%ID/g) uptake and immunohistochemical characterization. RESULTS:The uptake of scV/Tc in the proximal aorta, calculated from SPECT/CT co-registered scans as %ID, was significantly higher in the diabetic mice (0.036 ± 0.017%ID) compared to non-diabetic mice (0.017 ± 0.005%ID; P < 0.01), as was uptake measured as %ID/g in harvested aorta, 1.81 ± 0.50%ID/g in the diabetic group vs. 0.98 ± 0.25%ID/g in the non-diabetic group (P < 0.01). The nonspecific uptake of in-scV/Tc in proximal aorta was significantly lower than the uptake of functionally active scV/Tc. Immunostaining of the atherosclerotic lesions showed higher expression of VEGFR-1 and VEGFR-2 in the diabetic mice. CONCLUSION:These initial results suggest that imaging VEGFR with scV/Tc shows promise as a non-invasive approach to identify accelerated atherosclerosis.

journal_name

EJNMMI Res

journal_title

EJNMMI research

authors

Tekabe Y,Kollaros M,Zerihoun A,Zhang G,Backer MV,Backer JM,Johnson LL

doi

10.1186/s13550-014-0041-7

subject

Has Abstract

pub_date

2014-12-01 00:00:00

pages

41

issue

1

issn

2191-219X

journal_volume

4

pub_type

杂志文章
  • Mode of progression after radioembolization in patients with colorectal cancer liver metastases.

    abstract:BACKGROUND:Radioembolization is an established treatment modality in colorectal cancer patients with liver-dominant disease in a salvage setting. Selection of patients who will benefit most is of vital importance. The aim of this study was to assess response (and mode of progression) at 3 months after radioembolization...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-020-00697-z

    authors: van Roekel C,Jongen JMJ,Smits MLJ,Elias SG,Koopman M,Kranenburg O,Borel Rinkes IHM,Lam MGEH

    更新日期:2020-09-22 00:00:00

  • Low septal to lateral wall 18F-FDG ratio is highly associated with mechanical dyssynchrony in non-ischemic CRT candidates.

    abstract:BACKGROUND:In order to better understand the concept of mechanical dyssynchrony, a promising hallmark of cardiac resynchronization therapy (CRT) response, we investigated its effect on regional myocardial metabolism and myocardial blood flow (MBF) in non-ischemic CRT candidates. RESULTS:Thirty consecutive non-ischemic...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-019-0575-9

    authors: Degtiarova G,Claus P,Duchenne J,Cvijic M,Schramm G,Nuyts J,Voigt JU,Gheysens O

    更新日期:2019-12-09 00:00:00

  • Photonuclear production, chemistry, and in vitro evaluation of the theranostic radionuclide 47Sc.

    abstract:BACKGROUND:In molecular imaging and nuclear medicine, theranostic agents that integrate radionuclide pairs are successfully being used for individualized care, which has led to rapidly growing interest in their continued development. These compounds, which are radiolabeled with one radionuclide for imaging and a chemic...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-019-0515-8

    authors: Loveless CS,Radford LL,Ferran SJ,Queern SL,Shepherd MR,Lapi SE

    更新日期:2019-05-16 00:00:00

  • Assessment of regional pulmonary blood flow using 68Ga-DOTA PET.

    abstract:BACKGROUND:In vivo determination of regional pulmonary blood flow (PBF) is a valuable tool for the evaluation of many lung diseases. In this study, the use of 68Ga-DOTA PET for the in vivo quantitative determination of regional PBF is proposed. This methodology was implemented and tested in healthy pigs and validated u...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-017-0259-2

    authors: Velasco C,Mateo J,Santos A,Mota-Cobian A,Herranz F,Pellico J,Mota RA,España S,Ruiz-Cabello J

    更新日期:2017-12-01 00:00:00

  • Labeling of DOTA-conjugated HPMA-based polymers with trivalent metallic radionuclides for molecular imaging.

    abstract:BACKGROUND:In this work, the in vitro and in vivo stabilities and the pharmacology of HPMA-made homopolymers were studied by means of radiometal-labeled derivatives. Aiming to identify the fewer amount and the optimal DOTA-linker structure that provides quantitative labeling yields, diverse DOTA-linker systems were con...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-018-0372-x

    authors: Eppard E,de la Fuente A,Mohr N,Allmeroth M,Zentel R,Miederer M,Pektor S,Rösch F

    更新日期:2018-02-27 00:00:00

  • Long-term Ashtanga yoga practice decreases medial temporal and brainstem glucose metabolism in relation to years of experience.

    abstract:BACKGROUND:Yoga is increasingly popular worldwide with several physical and mental benefits, but the underlying neurobiology remains unclear. Whereas many studies have focused on pure meditational aspects, the triad of yoga includes meditation, postures, and breathing. We conducted a cross-sectional study comparing exp...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-020-00636-y

    authors: van Aalst J,Ceccarini J,Schramm G,Van Weehaeghe D,Rezaei A,Demyttenaere K,Sunaert S,Van Laere K

    更新日期:2020-05-14 00:00:00

  • The effect of isoflurane on 18F-FDG uptake in the rat brain: a fully conscious dynamic PET study using motion compensation.

    abstract:BACKGROUND:In preclinical positron emission tomography (PET) studies an anaesthetic is used to ensure that the animal does not move during the scan. However, anaesthesia may have confounding effects on the drug or tracer kinetics under study, and the nature of these effects is usually not known. METHOD:We have impleme...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-016-0242-3

    authors: Spangler-Bickell MG,de Laat B,Fulton R,Bormans G,Nuyts J

    更新日期:2016-12-01 00:00:00

  • Multiparametric magnetic resonance in the assessment of the gender differences in a high-grade glioma rat model.

    abstract:BACKGROUND:Glioblastoma, the most frequent and aggressive of all astrocytomas, presents a clear predominance in male humans, but the assessment of sexual differences in its tumourigenesis and growth has received little attention so far. In this study, we aim to identify gender-dependent surrogate markers in an animal m...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-014-0044-4

    authors: Pérez-Carro R,Cauli O,López-Larrubia P

    更新日期:2014-12-01 00:00:00

  • Potential for imaging the high-affinity state of the 5-HT1B receptor: a comparison of three PET radioligands with differing intrinsic activity.

    abstract:BACKGROUND:Over the last decade, a few radioligands have been developed for PET imaging of brain 5-HT1B receptors. The 5-HT1B receptor is a G-protein-coupled receptor (GPCR) that exists in two different agonist affinity states. An agonist ligand is expected to be more sensitive towards competition from another agonist,...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-019-0570-1

    authors: Lindberg A,Arakawa R,Nogami T,Nag S,Schou M,Elmore CS,Farde L,Pike VW,Halldin C

    更新日期:2019-11-21 00:00:00

  • Peptide receptor radionuclide therapy (PRRT) with [(177)Lu-DOTA(0),Tyr(3)]octreotate in combination with RAD001 treatment: further investigations on tumor metastasis and response in the rat pancreatic CA20948 tumor model.

    abstract:BACKGROUND:Previously, we reported on the unexpected development of distant metastases in the subcutaneous rat pancreas CA20948 tumor model after 4.5 weeks of treatment with RAD001-only or in combination with [(177)Lu-DOTA(0),Tyr(3)]octreotate ((177)Lu-DOTATATE) (Cancer Res. 73:12-8, 2013). Moreover, the combination th...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-014-0021-y

    authors: Bison SM,Pool SE,Koelewijn SJ,van der Graaf LM,Groen HC,Melis M,de Jong M

    更新日期:2014-05-30 00:00:00

  • Kinetic analysis of HER2-binding ABY-025 Affibody molecule using dynamic PET in patients with metastatic breast cancer.

    abstract:BACKGROUND:High expression of human epidermal growth factor receptor type 2 (HER2) represents an aggressive subtype of breast cancer. Anti-HER2 treatment requires a theragnostic approach wherein sufficiently high receptor expression in biopsy material is mandatory. Heterogeneity and discordance of HER2 expression betwe...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-020-0603-9

    authors: Alhuseinalkhudhur A,Lubberink M,Lindman H,Tolmachev V,Frejd FY,Feldwisch J,Velikyan I,Sörensen J

    更新日期:2020-03-23 00:00:00

  • Metabolic liver function in humans measured by 2-18F-fluoro-2-deoxy-D-galactose PET/CT-reproducibility and clinical potential.

    abstract:BACKGROUND:PET/CT with the radioactively labelled galactose analogue 2-18F-fluoro-2-deoxy-D-galactose (18F-FDGal) can be used to quantify the hepatic metabolic function and visualise regional metabolic heterogeneity. We determined the day-to-day variation in humans with and without liver disease. Furthermore, we examin...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-017-0320-1

    authors: Bak-Fredslund KP,Lykke Eriksen P,Munk OL,Villadsen GE,Keiding S,Sørensen M

    更新日期:2017-08-29 00:00:00

  • Effects of common anesthetic agents on [18F]flumazenil binding to the GABAA receptor.

    abstract:BACKGROUND:The availability of GABAA receptor binding sites in the brain can be assessed by positron emission tomography (PET) using the radioligand, [18F]flumazenil. However, the brain uptake and binding of this PET radioligand are influenced by anesthetic drugs, which are typically needed in preclinical imaging studi...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-016-0235-2

    authors: Palner M,Beinat C,Banister S,Zanderigo F,Park JH,Shen B,Hjoernevik T,Jung JH,Lee BC,Kim SE,Fung L,Chin FT

    更新日期:2016-12-01 00:00:00

  • Quantification of pulmonary disease activity in sarcoidosis measured with 18F-FDG PET/CT: SUVmax versus total lung glycolysis.

    abstract:BACKGROUND:18F-FDG PET/CT has proven to be a reliable tool for therapy monitoring in sarcoidosis. Previous PET studies investigated the SUVmax as a marker for disease activity. Total lung glycolysis (TLuG) is a new tool, quantifying the glycolysis of the entire lung. Since SUVmax represents the maximum activity in only...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-019-0505-x

    authors: Schimmelpennink MC,Vorselaars ADM,Veltkamp M,Keijsers RGM

    更新日期:2019-06-13 00:00:00

  • Sorafenib increases 18-FDG colic uptake: demonstration in patients with differentiated thyroid cancer.

    abstract:BACKGROUND:To assess 18-fluorodeoxyglucose (FDG) bowel uptake in patients with differentiated thyroid cancer (DTC) treated with sorafenib. FINDINGS:Visual (5-point scale) and high maximum standard uptake value (SUVmax) semi-quantitative analyses were conducted in 63 positron emission tomography (PET) studies performed...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/2191-219X-2-18

    authors: Ciappuccini R,Trzepla G,Heutte N,Sevin E,Galais MP,Bardet S

    更新日期:2012-05-07 00:00:00

  • Optimal MRI sequences for 68Ga-PSMA-11 PET/MRI in evaluation of biochemically recurrent prostate cancer.

    abstract:BACKGROUND:PET/MRI can be used for the detection of disease in biochemical recurrence (BCR) patients imaged with 68Ga-PSMA-11 PET. This study was designed to determine the optimal MRI sequences to localize positive findings on 68Ga-PSMA-11 PET of patients with BCR after definitive therapy. Fifty-five consecutive prosta...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-017-0327-7

    authors: Lake ST,Greene KL,Westphalen AC,Behr SC,Zagoria R,Small EJ,Carroll PR,Hope TA

    更新日期:2017-09-19 00:00:00

  • Interobserver agreement of [68Ga]Ga-PSMA-11 PET/CT images interpretation in men with newly diagnosed prostate cancer.

    abstract:BACKGROUND:Prostate-specific membrane antigen (PSMA) ligand PET/CT has already provided promising results in prostate cancer (PC) imaging, yet simple and reproductible reporting criteria are still lacking. This study aimed at retrospectively evaluating interobserver agreement of [68Ga]Ga-PSMA-11 PET/CT images interpret...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-020-0596-4

    authors: Derwael C,Lavergne O,Lovinfosse P,Nechifor V,Salvé M,Waltregny D,Hustinx R,Withofs N

    更新日期:2020-02-28 00:00:00

  • A comparative PET imaging study with the reversible and irreversible EGFR tyrosine kinase inhibitors [(11)C]erlotinib and [(18)F]afatinib in lung cancer-bearing mice.

    abstract:BACKGROUND:Tyrosine kinase inhibitors (TKIs) have experienced a tremendous boost in the last decade, where more than 15 small molecule TKIs have been approved by the FDA. Unfortunately, despite their promising clinical successes, a large portion of patients remain unresponsive to these targeted drugs. For non-small cel...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-015-0088-0

    authors: Slobbe P,Windhorst AD,Stigter-van Walsum M,Smit EF,Niessen HG,Solca F,Stehle G,van Dongen GA,Poot AJ

    更新日期:2015-03-20 00:00:00

  • Impact of inherent variability and experimental parameters on the reliability of small animal PET data.

    abstract:BACKGROUND:Noninvasive preclinical imaging methodologies such as small animal positron emission tomography (PET) allow the repeated measurement of the same subject which is generally assumed to reduce the variability of the experimental outcome parameter and to produce more robust results. In this study, the variabilit...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/2191-219X-2-26

    authors: Martic-Kehl MI,Ametamey SM,Alf MF,Schubiger PA,Honer M

    更新日期:2012-06-09 00:00:00

  • Optimization of [11C]methionine PET study: appropriate scan timing and effect of plasma amino acid concentrations on the SUV.

    abstract:BACKGROUND:[11C]methionine (MET) has been used to monitor amino acid metabolism in tumors, the pancreas, liver, and myocardium. The aim of the present study was to standardize [11C]MET positron emission tomography (PET) by optimizing the timing of initiation of the scan and applying correction to the plasma concentrati...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/2191-219X-3-27

    authors: Isohashi K,Shimosegawa E,Kato H,Kanai Y,Naka S,Fujino K,Watabe H,Hatazawa J

    更新日期:2013-04-15 00:00:00

  • First in-human radiation dosimetry of the gastrin-releasing peptide (GRP) receptor antagonist 68Ga-NODAGA-MJ9.

    abstract:BACKGROUND:Gastrin-releasing peptide receptor antagonists have promise in theranostics of several highly incident tumours, including prostate and breast. This study presents the first human dosimetry of 68Ga-NODAGA-MJ9 in the first five consecutive patients with recurrent prostate cancer included in a dual-tracer posit...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-018-0462-9

    authors: Gnesin S,Cicone F,Mitsakis P,Van der Gucht A,Baechler S,Miralbell R,Garibotto V,Zilli T,Prior JO

    更新日期:2018-12-12 00:00:00

  • SPECT image segmentation for estimation of tumour volume and activity concentration in 177Lu-DOTATATE radionuclide therapy.

    abstract:BACKGROUND:Dosimetry in radionuclide therapy has the potential to allow for a treatment tailored to the individual patient. One therapeutic radiopharmaceutical where patient-specific dosimetry is feasible is 177Lu-DOTATATE, used for the treatment of neuroendocrine tumours. The emission of gamma photons by 177Lu allows ...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-017-0262-7

    authors: Gustafsson J,Sundlöv A,Sjögreen Gleisner K

    更新日期:2017-12-01 00:00:00

  • Concordance between in vivo and postmortem measurements of cholinergic denervation in rats using PET with [18F]FEOBV and choline acetyltransferase immunochemistry.

    abstract:BACKGROUND:Fluorine-18 fluoroethoxybenzovesamicol ([18F]FEOBV) is a radioligand for the selective imaging of the vesicular acetylcholine transporter with positron emission tomography (PET). The current study demonstrates that pathological cortical cholinergic deafferentation can be quantified in vivo with [18F]FEOBV PE...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/2191-219X-3-70

    authors: Parent MJ,Cyr M,Aliaga A,Kostikov A,Schirrmacher E,Soucy JP,Mechawar N,Rosa-Neto P,Bedard MA

    更新日期:2013-10-09 00:00:00

  • 99mTc-labelled S-HYNIC certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients: a biodistribution and dosimetry study.

    abstract:BACKGROUND:Biologicals directed against tumour necrosis factor (TNF) have proven their efficacy in the treatment of spondyloarthritis and rheumatoid arthritis. We present a radiolabelling method for certolizumab pegol (CZP), a commercially available humanized Fab'-fragment directed against TNF. A biodistribution and do...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-016-0245-0

    authors: Lambert B,Carron P,D'Asseler Y,Bacher K,Van den Bosch F,Elewaut D,Verbruggen G,Beyaert R,Dumolyn C,De Vos F

    更新日期:2016-12-01 00:00:00

  • 18F-FDG and 68Ga-somatostatin analogs PET/CT in patients with Merkel cell carcinoma: a comparison study.

    abstract:BACKGROUND:Merkel cell carcinoma (MCC) is an aggressive neuroendocrine skin tumor. Currently, 18F-fluoro-deoxy-glucose (18F-FDG) PET/CT is the functional imaging modality of choice. Few data are available on the use of 68Ga-somatostatin analogs. The aim of our study was to evaluate and compare the diagnostic performanc...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-018-0423-3

    authors: Taralli S,Sollini M,Milella M,Perotti G,Filice A,Menga M,Versari A,Rufini V

    更新日期:2018-07-21 00:00:00

  • Advanced brain dopamine transporter imaging in mice using small-animal SPECT/CT.

    abstract:UNLABELLED: BACKGROUND:Iodine-123-β-CIT, a single-photon emission computed tomography (SPECT) ligand for dopamine transporters (DATs), has been used for in vivo studies in humans, monkeys, and rats but has not yet been used extensively in mice. To validate the imaging and analysis methods for preclinical DAT imaging, ...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/2191-219X-2-55

    authors: Pitkonen M,Hippeläinen E,Raki M,Andressoo JO,Urtti A,Männistö PT,Savolainen S,Saarma M,Bergström K

    更新日期:2012-09-29 00:00:00

  • Simplifying [18F]GE-179 PET: are both arterial blood sampling and 90-min acquisitions essential?

    abstract:INTRODUCTION:The NMDA receptor radiotracer [18F]GE-179 has been used with 90-min scans and arterial plasma input functions. We explored whether (1) arterial blood sampling is avoidable and (2) shorter scans are feasible. METHODS:For 20 existing [18F]GE-179 datasets, we generated (1) standardised uptake values (SUVs) o...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-018-0396-2

    authors: McGinnity CJ,Riaño Barros DA,Trigg W,Brooks DJ,Hinz R,Duncan JS,Koepp MJ,Hammers A

    更新日期:2018-06-11 00:00:00

  • Comparison of four 11C-labeled PET ligands to quantify translocator protein 18 kDa (TSPO) in human brain: (R)-PK11195, PBR28, DPA-713, and ER176-based on recent publications that measured specific-to-non-displaceable ratios.

    abstract::Translocator protein (TSPO) is a biomarker for detecting neuroinflammation by PET. 11C-(R)-PK11195 has been used to image TSPO since the 1980s. Here, we compared the utility of four 11C-labeled ligands-(R)-PK11195, PBR28, DPA-713, and ER176-to quantify TSPO in healthy humans. For all of these ligands, BP ND (specific-...

    journal_title:EJNMMI research

    pub_type: 信件

    doi:10.1186/s13550-017-0334-8

    authors: Fujita M,Kobayashi M,Ikawa M,Gunn RN,Rabiner EA,Owen DR,Zoghbi SS,Haskali MB,Telu S,Pike VW,Innis RB

    更新日期:2017-10-16 00:00:00

  • Non-invasive molecular imaging of inflammatory macrophages in allograft rejection.

    abstract:BACKGROUND:Macrophages represent a critical cell type in host defense, development and homeostasis. The ability to image non-invasively pro-inflammatory macrophage infiltrate into a transplanted organ may provide an additional tool for the monitoring of the immune response of the recipient against the donor graft. We t...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-015-0146-7

    authors: O'Neill AS,Terry SY,Brown K,Meader L,Wong AM,Cooper JD,Crocker PR,Wong W,Mullen GE

    更新日期:2015-12-01 00:00:00

  • The development of a GPR44 targeting radioligand [11C]AZ12204657 for in vivo assessment of beta cell mass.

    abstract:BACKGROUND:The G-protein-coupled receptor 44 (GPR44) is a beta cell-restricted target that may serve as a marker for beta cell mass (BCM) given the development of a suitable PET ligand. METHODS:The binding characteristics of the selected candidate, AZ12204657, at human GPR44 were determined using in vitro ligand bindi...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-018-0465-6

    authors: Jahan M,Johnström P,Selvaraju RK,Svedberg M,Winzell MS,Bernström J,Kingston L,Schou M,Jia Z,Skrtic S,Johansson L,Korsgren O,Farde L,Halldin C,Eriksson O

    更新日期:2018-12-27 00:00:00